Skip to main content

Pharma Value Demonstration Makes Recommended Cash Offer to Acquire Cello Health plc

July 1, 2020

Pharma Value Demonstration, a portfolio company of Arsenal, reached an agreement with the board of Cello Health plc on the terms of a recommended cash offer for the entire issued, and to be issued, share capital of Cello. 

To read the announcement and other relevant documentation, please visit www.pharma-value-demonstration.com.